Development of a model to demonstrate the impact of National Institute of Health and Care Excellence cost-effectiveness assessment on health utility for targeted medicines. (2022)
Attributed to:
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/hec.4459
PubMed Identifier: 34825428
Publication URI: http://europepmc.org/abstract/MED/34825428
Type: Journal Article/Review
Volume: 31
Parent Publication: Health economics
Issue: 2
ISSN: 1057-9230